Mancera Gracia JC, Van den Hoecke S, Richt JA, Ma W, Saelens X, Van Reeth K. H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs. Evolution of Diagnostic Tests for Chronic Wasting Disease, a Naturally Occurring Prion Disease of Cervids. Genotypes of hepatitis a virus in Turkey: first report and clinical profile of children infected with sub-genotypes IA and IIIA. Yilmaz H, Karakullukcu A, Turan N, Cizmecigil UY, Yilmaz A, Ozkul AA, Aydin O, Gunduz A, Mete M, Zeyrek FY, Kirazoglu TT, Richt JA, Kocazeybek B. Phenotyping and susceptibility of established porcine cells lines to African Swine Fever Virus infection and viral production. Sánchez EG, Riera E, Nogal M, Gallardo C, Fernández P, Bello-Morales R, López-Guerrero JA, Chitko-McKown CG, Richt JA, Revilla Y. Current Status of Rift Valley Fever Vaccine Development. Faburay B, LaBeaud AD, McVey DS, Wilson WC, Richt JA. Estimating chronic wasting disease susceptibility in cervids using real-time quaking-induced conversion. Haley NJ, Rielinger R, Davenport KA, O'Rourke K, Mitchell G, Richt JA. Yolanda Revilla, Daniel Pérez-Núñez and Juergen A. Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus. Sally Davis, Sun Young Sunwoo, Yuekun Lang, Michael Duff, Igor Morozov, Yuhao Li, Jianmei Yang, Adolfo García-Sastre, Juergen A. Jingjiao Ma, Jinhwa Lee, Haixia Liu, Ignacio Mena, A. public health and agricultural systems from devastating animal and zoonotic diseases Selected PublicationsĬomplete List of Published work in MyBibliography: As founding Director of the DHS CEEZAD and the NIH CEZID Centers, our laboratory is supporting NIH, DHS and USDA in protecting U.S. Our recent work focuses on the establishment of preclinical animal models for SARS-CoV-2 in pigs, cats, hamsters and ferrets in order to evaluate the efficacy of COVID-19 vaccines and therapeutics. For ASFV, we are developing subunit and modified live virus vaccine candidates as well as point-of-need diagnostic tools (PenCheckTM) to protect swine from this devastating disease. Our RVFV work led to the development of novel domestic and wild ruminant models for RVF and a safe, efficacious, and DIVA-compatible subunit RVF vaccine. We identified an atypical BSE case with a causative mutation ("genetic BSE"), used gene-editing approaches to develop the first prion protein knock-out cattle that are resistant to prion infection, and provided valuable information on host range of animal prions essential for risk analysis. We also worked on the isolation and characterization of novel swine influenza virus subtypes including the H2N3 reassortant virus and the 2009 pandemic H1N1 virus, and studied their zoonotic potential using nonhuman primate models. as Ingelvac Provenza™), and contributed to understanding the virulence of the reconstructed 1918 "Spanish Flu" virus in livestock. My lab established the first reverse genetics system for SIVs, made seminal contributions to the development of a modified live SIV vaccine (sold in the U.S. The overall goal of my research is to investigate zoonotic, emerging and transboundary diseases of livestock focusing mainly on viral diseases. 
I hold the prestigious Regents Distinguished and University Distinguished Professor appointments at Kansas State University. Currently, I am the Director of the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) and the NIH COBRE Center on Emerging and Zoonotic Infectious Diseases (CEZID). I am an editor for Virus Genes and serve on editorial boards for other scientific journals. On these topics, I have published more than 250 peer-reviewed scientific manuscripts. Regents Distinguished Professor, Diagnostic Medicine Pathobiologyĭuring my 25+ year scientific career, I have studied pathogen-host interactions in various infectious disease models including Avian and Swine Influenza viruses (AIV, SIV), African Swine Fever virus (ASFV), Rift Valley Fever virus (RVFV), Vesicular Stomatitis virus (VSV), Schmallenberg virus (SBV), animal prion diseases and Borna Disease Virus (BDV). PhD Virology (1988), University of Giessen, Germany
NIH COBRE Center on Emerging and Zoonotic Infectious Diseases (CEZID) DVM (1985), University of München, Germany Richt Regents Distinguished Professor & KBA Eminent ScholarĬenter of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Director
0 kommentar(er)
